Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have been diagnosed with Hereditary Spastic Paraplegia.
- People who have some loss of function in their legs that affects how they walk, such as muscle weakness, stiffness, or balance problems.
- People who are able to walk without needing another person to physically support or hold them (a standard walking ability assessment score of 3 or higher is used to measure this).
- People who can understand simple instructions, understand what the study involves, are willing to take part, and are able to attend at least 10 treatment sessions and sign a consent form.
Who may not be able to join:
- People who have had Botulinum toxin injections (such as Botox) or surgery to treat leg stiffness within the six months before joining the study.
- People for whom moderate physical activity — such as stretching, strength training, or aerobic exercise — would not be medically safe (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Leonardo Boccuni, PhD, Scientific Institute, IRCCS E. Medea, Department of Conegliano, Treviso, Italy.
Phone: 003904384141
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility (recruitment rate).; Feasibility (adherence rate).; Feasibility (retention rate).; Feasibility (safety).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.